Medical Device Registration as the Prerequisite for Market Access in Russia

1. Key takeaways

Russia operates a strict registration-first regime for medical devices: a device may not be manufactured, imported, sold, or used in the country until it has completed registration and been entered into the national register. This is not a soft administrative preference but a hard gate enforced at customs, at distribution, and at the point of clinical use. Foreign approvals carry no standalone market-access weight in Russia: a CE certificate, an FDA clearance, or an NMPA registration certificate demonstrates quality elsewhere, yet none of them constitutes a legal basis for placing a device on the Russian market. Many international manufacturers discover this only after a shipment has been held at the border, which is why the registration question should be resolved before any commercial commitment is signed, not after.

Two lawful entry routes exist today. The first is national registration under Russian rules, which results in a national registration certificate (RU). The second is registration under the rules of the Eurasian Economic Union (EAEU), which results in a union registration certificate valid across the member states. The window for filing new applications under the Russian national rules closes on December 31, 2027. After that date, new devices will need to follow the EAEU route, while existing national certificates remain manageable under the national framework for a further period. Understanding which route applies to your portfolio, and by when, is the single most consequential planning decision in this market.

2. Legal basis

3. Expert insights

Insight 1: Registration is the only gateway. Since January 1, 2021, medical devices have been removed from the list of products subject to mandatory conformity declaration under Government Resolution No. 982. The earlier dual-procedure structure, in which a device needed both registration and a GOST-R declaration of conformity, has disappeared. Regulatory attention is now concentrated on the single checkpoint of registration, and any scheme that attempts to substitute a conformity document for a registration certificate does not work in Russia. Distributors and procurement teams should be trained accordingly: a supplier presenting a declaration or a certificate of conformity in place of a registration certificate is not offering a compliant product. This concentration also simplifies diligence, because one authoritative record, the national register, answers the compliance question for any device on the market.

Insight 2: Registration covers the unit, not the product name. Whether a shipped item is covered by an existing registration is judged against four elements: the manufacturer, the manufacturing site address, the model including its configuration, and the intended purpose. If any one of these differs from the registered record, the item is an unregistered device, regardless of marketing names or family branding. GRZAN places this four-element comparison as the first item in its combined compliance checks, because it is the most frequent source of disputes at customs and during market surveillance. Minor design evolutions, changed suppliers of components that alter the declared configuration, or re-labelling for a different intended use can all silently push a product outside the scope of its certificate.

Insight 3: Two routes, two deadlines, do not mix them. New applications under the national rules are accepted only until December 31, 2027. The national registration rules themselves, as adopted by Resolution No. 1684, remain in force until December 31, 2028. The first date governs whether you can still start a new national application at all; the second governs how long existing national certificates can continue to be managed, varied, and amended under the national framework. Companies that conflate the two dates either rush filings that could have been planned calmly, or wrongly assume that a certificate obtained before the deadline can still be newly filed afterward. Portfolio mapping against both dates is essential.

4. Practical recommendations

1. At project initiation, lock down the four scope elements: manufacturer, manufacturing site address, model and configuration, and intended purpose. Write them into the specification annex of commercial contracts so that every later change is visible and controlled.
2. If new products will still be introduced to Russia after December 31, 2027, begin preparing the evidence package now at the depth required by the EAEU rules. This avoids redoing foundational testing such as biocompatibility, electrical safety, or performance verification at a later stage under time pressure.
3. When presenting CE or FDA documentation to Russian customers or authorities, mark it clearly as not applicable to circulation in the Russian Federation. Such documents may support internal quality assurance, but they must never be presented as proof of registration.
4. Maintain a portfolio register that records, for each product, the applicable route, the target filing date, and the responsible owner, so that the 2027 cut-off is monitored at management level rather than discovered by an individual specialist.

5. Verification checklist

• □ Every model can be located in the RZN national register or the EAEU unified register with a corresponding record
• □ The manufacturer and manufacturing site address in the register record match the physical product label
• □ If the national route is used, the filing date precedes December 31, 2027
• □ The specification annex of commercial contracts matches the model configuration stated in the registration documents
• □ Registration evidence provided externally contains the elements of the register record, not merely a colored copy of the certificate
• □ No declaration of conformity, certification report, or voluntary GOST certificate has been used as a substitute for the registration certificate

GRZAN provides end-to-end regulatory support for manufacturers entering the Russian market, covering both national RZN registration and EAEU registration pathways. Our team assists with route selection against the 2027 national filing deadline, type code and risk class determination, registration dossier preparation, testing coordination, authorized representative services, and post-registration change management. Whether you are planning your first filing or consolidating an existing portfolio across the two routes, GRZAN can help you sequence submissions, maintain register consistency, and keep certificates compliant after approval. Contact us at info@grzanglobal.com to discuss your project.

Regulatory information verified as of October 29, 2026.